Divi's Laboratories Limited is a leading manufacturer and distributor of generic active pharmaceutical ingredients (APIs) and intermediates, as well as nutraceutical ingredients. With a strong presence in India, the United States, Asia, Europe, and other international markets, the company caters to the diverse needs of the pharmaceutical, food/beverage, nutritional, and feed industries. In addition to its core business, Divi's Laboratories also specializes in custom synthesis of APIs and intermediates, offering tailored solutions to its clients. Originally established as Divi's Research Center, the company rebranded itself as Divi's Laboratories Limited in 1994. Since its inception in 1990, the company has been headquartered in Hyderabad, India.
Navigation section
Divi's Laboratories Limited
- 5,951.85 -178.90(-2.92%) 5,959.75 -170.35(-2.78%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 5,937.65 5,931.70 | 6,041.55 6032.95 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 3,350.00 (27-Mar-2024) 3,350.05 (27-Mar-2024) | 6,285.45 (03-Dec-2024) 6,448.75 (02-Dec-2024) |
- Open
- 5,999.95 6,025.60
- Previous Close
- 6,130.75 6,130.10
- Volume
- 11.23
- Total Traded value
- 671.22 (₹ Lakhs)
- Upper circuit
- 6,743.80 4,271.10
- Lower circuit
- 5,517.70 3,494.60
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 67 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 5,959.65 | 67.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 67 |
Fundamentals
| Market Cap: | ₹1,580.03 Cr |
| PE Ratio (TTM): | 86.12 |
| PB Ratio: | 11.60 |
| Industry P/E: | 88.64 |
| Debt to Equity: | - |
| ROE: | 13.47 |
| EPS (TTM): | 69.20 |
| Book Value: | 13.61 |
| Face Value: | 2.00 |
Financials
| Mar, 2023 | Sep, 2022 | Sep, 2023 | Dec, 2022 | Jun, 2023 | |
|---|---|---|---|---|---|
| Revenue | 199.07 Cr | 4,552.15 Cr | 50.77 Cr | 9.51 Cr | 1,730.00 Cr |
| Profit | -46.05 Cr | 1,200.23 Cr | -1.27 Cr | 0.57 Cr | 345.00 Cr |
| Expense | 196.91 Cr | 5,198.25 Cr | 52.49 Cr | 9.26 Cr | 1,332.00 Cr |
| Comprehensive income | -45.84 Cr | 1,268.07 Cr | -1.27 Cr | 0.57 Cr | 346.00 Cr |
| EPS | -2.44 | 3.75 | -0.07 | 0.01 | 12.99 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Divi's Laboratories Limited | Mar, 2003 Mar, 2003 | Pharmaceuticals Pharmaceuticals | DIVISLAB DIVISLAB |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Divi's Laboratories Limited FAQ's
What is the range of today's stock performance for Divi's Laboratories Limited?
Today's stock performance witnessed a fluctuation from a minimum of 5,937.65 on the NSE (National Stock Exchange) to a maximum of 6,041.55. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 5,931.70 to a high of 6,032.95.
What are the 52-week low and high values for Divi's Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 3,350.00 (occurred on 27-Mar-2024) and a high of 6,285.45 (achieved on 03-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 3,350.05 (on 27-Mar-2024), and the 52-week high is 6,448.75 (on 02-Dec-2024).
What was the opening and previous closing prices for Divi's Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 3,350.00 (occurred on 27-Mar-2024) and a high of 6,285.45 (achieved on 03-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 3,350.05 (on 27-Mar-2024), and the 52-week high is 6,448.75 (on 02-Dec-2024).
What is the total volume and traded value for Divi's Laboratories Limited for the day?
The total volume is 11, and the total traded value is 671.22 (₹ Lakhs).
What are the upper and lower circuit limits for Divi's Laboratories Limited?
The upper circuit limit is 6,743.80, and the lower circuit limit is 5,517.70.
What is the market cap and PE ratio for Divi's Laboratories Limited?
The market cap is ₹1,580.03 Cr, and the PE ratio (TTM) is 88.64.
What is the PB ratio, industry P/E, and debt to equity ratio for Divi's Laboratories Limited?
The PB ratio is 437.26, industry P/E is 88.64 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Divi's Laboratories Limited?
ROE is 13.47, EPS is 69.20, book value is 13.61
What are the revenue and profit figures for the latest quarter and previous quarters for Divi's Laboratories Limited?
In Mar 2023, Revenue is ₹1990661000.00, and Profit is ₹-460520000.00. In Sep 2022, Revenue is ₹45521500000, and Profit is ₹12002300000.
When was Divi's Laboratories Limited listed, and what industry does it belong to?
The company, Divi's Laboratories Limited, was listed in Mar 2003 and belongs to the Pharmaceuticals industry. Its NSE symbol is DIVISLAB.
What is the current shareholding pattern of the Divi's Laboratories Limited?
As of latest available update, promoters hold 51.93%, the public holds 48.07%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 95
